SAS 10: ADRENORECEPTOR AGNOST AND SYMPATHOMIMETIC DRUGS Flashcards

1
Q

what is the precursor of the effect in symptomatic again?

A

release of the NE and binding to receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

acts as neurotransmitter in adrenergic transmission

A

Norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a cholinomimetic that acts more like a hormone

A

Epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the MOA of direct agonist?

A

directly interact and activate adrenoreceptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the MOA of indirect agonist?

A

enhances the affinity of the endogenous catecholamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the endogenous cathecholamines?

A

Dopamine
Norepinephrine
Epinephrine (adrenaline)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the different mechanism of indirect agonist?

A

> displaces stored catecholamines in the adrenergic nerve ending
inhibits re-uptake of the released catecholamines
prevents the metabolic enzyme in the synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

> displaces stored catecholamines in the adrenergic nerve ending

: what are the mixed sympathomimetics (indirect-acting) that are capable of releasing stored transmitters from noradrenergic nerve endings by a CALCIUM INDEPENDENT PROCESS

A

tyramine, amphetamine, ephedrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

> inhibits re-uptake of the released catecholamines

: what are the drugs that can inhibit the NET?

A

Imipramine(anti-depressant)
cocaine
duloxetine(norepinephrine-serotonin re-uptake inhibitors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

> prevents the metabolic enzyme in the synaptic cleft

: what are 2 major enzymes responsible for the metabolism in the synaptic cleft

A

Monoamine oxidase
Catechol-o-methyltransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what type of receptor is Adrenoreceptor

A

G-coupled receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the post-receptor in the adrenergic transmission again?

A

dopamine, alpha, beta receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what type of G-protein is the a1 receptor?

A

Gq

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the effects of a1 receptor?

A

increase in IP3 and DAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what type of G-protein is the a2 receptor?

A

Gi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the effect of a2 receptor?

A

decrease in cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what type of G-protein is the beta receptor?

A

Gs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what type of G-protein is the D1 and D5 receptor?

A

Gs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what type of G-protein is the D2-D4 receptor?

A

Gi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

if a2 is decrease in cAMP then beta receptor is?

A

increase in cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Phenylephrine is what agonist receptor?

A

a1 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Clonidine is what agonist receptor?

A

a2 receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Isoproterenol is what agonist receptor?

A

Beta receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Does dopamine have an antagonist?

A

None

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
what is IP3 stands for?
1,4,5-triphosphate
26
This enzyme hydrolyzes polyphosphoinositides, leading to the formation of inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG).
Alpha 1 receptor
27
This receptors inhibit adenylyl cyclase activity and cause intracellular cyclic adenosine monophosphate (cAMP) levels to decrease.
Alpha 2 receptor
28
is the major second messenger of the b-receptor activation
Cyclic AMP
29
what is the CAUSE of the increase in the influx of calcium across the cell membrane and its sequestration inside the cell.
increase in cAMP
30
is typically associated with the stimulation of adenylyl cyclase
D1 receptor
31
have been found to inhibit adenylyl cyclase activity, open potassium channels and decrease calcium influx
D2 receptor
32
a drug may preferentially bind to one subgroup of receptors at low concentration but when at high interact with related class receptors.
selectivity
33
considers the parent compound of sympathomimetic
Phenylethylamine
34
what forms a sympathomimetic drugs (known as catecholamines)
-OH substitution in the 3 and 4 positions of the benzene ring
35
a synthetic catecholamines - very potent b-receptor agonist; little effect on a receptor.
Isoproterenol
36
The absence of one or the other of these groups, particularly the hydroxyl at C3 without other substitutions on the ring may dramatically, what?
reduce the potency of the drug
37
why catecholamines is inactive orally?
COMT (metabolic enzyme) is only found in the gut and liver
38
This increases the bioavailability orally and prolongs action; and, this also increases distribution in the CNS.
absence of one or both -OH in the benzene ring
39
an increase in the alkyl substituents may, what?
increase B-receptor activity
40
an increase in the alkyl substituents may, what?
increase B-receptor activity
41
a substituent to the alpha carbon may, what?
blocks MAO hence, increase activity
42
alpha carbon-substituent is called
phenylisopropylamines
43
a substitution in this creates a direct-acting sympathomimetic drugs expect dopamine drug affinity
beta carbon substitution
44
-leads to arterial and venous vasoconstriction *phenylephrine increases peripheral arterial resistance and decreases venous capacitance. (The ENHANCED ARTERIAL RESISTANCE USUALLY LEADS TO DOSE-DEPENDENT rise in blood pressure.)
activation of alpha 1 receptor
45
- leads to vasoconstriction when given locally in high dose (or thru IV) - leads to vasodilation when given systematically is activation of what receptor?
a2 receptor
46
is a nonselective β agonist; it activates both β1 and β2 receptors
Isoproterenol
47
activation of this receptor results in increased calcium influx in cardiac cell
B-receptor
48
Pacemaker activity involves?
increase chronotropy and dromotropy
49
Activation of ____________ IN THE RENAL VASCULATURE may also induce natriuresis.
activiation of D1 receptor
50
- Dopamine activates β1 receptors in the heart. - At low doses, peripheral resistance may decrease. At higher rates of infusion, dopamine activates vascular α receptors, leading to vasoconstriction.
Dopamine effect
51
Activation in _______________ in fat cells leads to _____________ with enhanced release of free fatty acids and glycerol into the blood
B adrenoreceptors leads to increased (lipolysis)
52
inhibit lipolysis by (decreasing) intracellular cAMP
a2 receptor in fat cells
53
Renin secretion is stimulated by ______ and inhibited by ______________
stimulated by b1; inhibited by a2 receptors
54
Renin secretion is inhibited by?
a2
55
Renin secretion is stimulated by?
B1
56
_______ with INdirect action (eg. amphetamines) readily enters the CNS from circulation which produces varying CNS effects. EFFECTS: mild altering, with improve attention to boring tasks; through elevation of mood, insomnia, euphoria, and anorexia; to either full-blown psychotic behavior
noncatecholamines
57
an agonist at both α and β receptors
Epinephrine
58
- examples are Levarterenol, noradrenaline - agonist at both α1 and α2 receptors
Norepinephrine
59
*the immediate precursor of norepinephrine
Dopamine
60
DIRECT-ACTING SYMPHATHOMIMETICS: has a longer duration of action than the catecholamines. It is an effective mydriatic and decongestant and can be used o raise the blood pressure.
Phenylephrine *Methoxamine
61
- prodrug that is enzymatically hydrolyzed to desglymidodrine, a selective α1-receptor agonist - the drug may treat hypotension but causes hypertension when laying
Midodrine
62
acts pharmacologically like *phenylephrine (predominantly a1 agonist)
Methoxamine
63
Clonidine, methyldopa, guanfacine, and guanabenz are examples of
A2 selective agonist
64
DEXmedetomidine
sedation of //initially// intubated/ and /mechanically/ ventilated patients during treatment in an intensive care setting.
65
sedation of //initially// intubated/ and /mechanically/ ventilated patients during treatment in an intensive care setting.
DEXmedetomidine
66
used as a central muscle relaxant
TIZAnidine
67
TIZAnidine
central muscle relaxant
68
Topical decongestants
Xylo-line, Oxy-line XYLOmetazoLINE and OXYmetazoLINE
69
Dobutamine
resembles dopamine but binds to a and b receptors
70
first orally active sympathomimetic drug found in Ma huang, a popular herbal medication.
Ephedrine
71
Ma huang, herbal
Ephedrine
72
component of many decongestant mixtures. *pseudo
pseudoephedrine
73
Phenylpropanolamine
common component in OTC appetite suppressants
74
Common, OTC *P
Phenylpropanolamine
75
similar to amphetamine but with higher ratio of central to peripheral actions *meth
methamphetamine
76
a variant of phenylisopropylamine with amphetamine-like effects. It has been promoted as an anorexiant and is also a popular drug of abuse.
Phenmetrazine
77
an amphetamine variant whose major pharmacologic effects and abuse potential are similar to those of amphetamine. -effective in children with ADHD
Methylphenidate
78
is psychostimulant that differs from amphetamine
Modafinil
79
byproduct of Tyrosine metabolism
Tyramine
80
Amphetamine, Methamphetamine, Phenmetrazine, Methylphenidate, Modafinil, Tyramine are example of what
Indirect-acting symphathomimetics
81
Atomoxetine, Reboxetine, Sibutramine, Duloxetine, Cocaine are example of what?
Catecholamine reuptake inhibitor
82
Fenoldopam and Levodopa are examples of what?
Dopamine agonist
83
why catecholamines cannot be given orally?
because they are greatly degraded in the liver and gastrointestinal mucosa. In contrary to non-catecholamines.